Paul Kelly
Board Member
Relmada Therapeutics, Inc. (RLMD)Equibles does not estimate personal net worth.
Get an email with a short summary when Relmada Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get RLMD alertsAbout Paul Kelly
Paul Kelly is recorded as Board Member and COO at Relmada Therapeutics, Inc. (RLMD). The newest filing on record that lists Paul Kelly as Board Member and COO at Relmada Therapeutics, Inc. (RLMD) is dated April 17, 2026. Relmada Therapeutics, Inc. reported in an 8-K filed December 15, 2025 that Paul Kelly was appointed Chief Operating Officer, effective January 1, 2025. Relmada Therapeutics, Inc. reported in an 8-K filed January 6, 2025 that Paul Kelly was appointed Chief Operating Officer, effective January 1, 2025. Relmada Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Relmada Therapeutics, Inc. includes Sergio Traversa (CEO and Board Member), Charles J. Casamento (Chairman and Board Member), Maged Shenouda (CFO) and 3 others.
“On behalf of Relmada Therapeutics, Inc: (the “Company”), I am pleased to offer you the position of Chief Operating Officer.”
“Effective January 1, 2025, Paul Kelly was elected by the Board of Directors (the “Board”) to the position of Chief Operating Officer of Relmada Therapeutics, Inc. (the “Company”).”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 17, 2026
-
Current
Start not stated–present
Last confirmed April 17, 2026
Company network
Leadership on record at Relmada Therapeutics, Inc.
- Sergio Traversa CEO, Board Member
- Charles J. Casamento Chairman, Board Member
- Maged Shenouda CFO
- Charles Ence Chief Accounting Officer
- Fabiana Fedeli Board Member
- John Glasspool Board Member